Biosimilars | Association for Accessible Medicines
Access! 2020 - Missed the early-bird? Save $300 off full-pass registration when you register by March 27



Please see below for shareable resources, press releases and other content relating to this issue. You can also use the search bar in the header of our website to search for specific keywords across all content on the site.

PDFJul 18, 2018Tony Kurilla
AAM Statement on FDA’s Biosimilars Action Plan
Download |
PDFApr 24, 2018Erica Klinger
AAM Biosimilars Council Policy Recommendations Biosimilars
Download |
Press Release Mar 7, 2019 Rachel Schwartz
AAM Statement on FDA Draft Guidance on Biosimilar Naming Requirements
Press Release Feb 6, 2018 Rachel Schwartz
AAM and the Biosimilars Council Call on Congress to Increase Patient Access to Biosimilars

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.